menu

MENU

繁體中文

Contact Us

Menu

Menu

Company

Introduction
Team & Board of Directors
Partners
Investors
Latest News

R&D Pipeline

Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy

Company

Introduction

Team & Board of Director

Partners

Investors

Latest News

R&D Pipeline

Overview

Intranasal Vaccines

Asthma Immunotherapy

Respiratory Antiviral Immunotherapy

Contact us

Latest News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

May 26, 2020

【工商時報】昱厚 申請COVID-19粘膜免疫治療專利

Press

April 10, 2020

【國衛院電子報】國衛院論壇「台灣新冠肺炎COVID-19疫苗緊急開發策略」專家諮詢會議

Press

February 17, 2020

LTh(αK) Conjugated Pneumococcal and Haemophilus Influenzae Type b Vaccine Granted U.S. Patent.

Updates

February 7, 2020

【健康醫療網】這家台灣公司疫苗佐劑已Ready　有望加速武漢肺炎疫苗研發

Press

December 11, 2019

The Final Clinical Study Report for the Phase II Trial of the Company's Intranasal Influenza Vaccine AD07030 Has Been Reviewed and Acknowledged for Record by the Taiwan Food and Drug Administration (TFDA).

Updates